Given that S1-directed plasma antibodies, particularly those targeting the RBD, account for virtually all SARS-CoV-2 neutralizing activity upon infection or vaccination (44, 46), we sought to determine if MERS-CoV infection-elicited antibodies share a similar specificity. This evidence concerns the gene PSMD1 and infection.